Nowa wersja platformy jest już dostępna.
Przejdź na


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2014 | 10 | 1 |
Tytuł artykułu

Surgical tracheotomy performed with and without dual antiplatelet therapy

Treść / Zawartość
Warianty tytułu
Języki publikacji
Some patients who need dual antiplatelet therapy sometimes require tracheotomy. Aim of this study was to compare the rate of complications during and after surgical tracheotomy between patients requiring dual antiplatelet therapy and those without dual antiplatelet therapy. We retrospectively included 79 patients (62% men, mean age 64 ± 14 years) in the period 2007- 2011. The following complications were analyzed: need for surgical revision within 24 hours after tracheotomy, need for bronchoscopy within 24 hour after tracheotomy, need for blood transfusion within 24 hours after tracheotomy, death attributed to tracheotomy and any complication attributed to tracheotomy. We compared patients where tracheotomy was performed while receiving dual antiplatelet therapy (n=27, 34%) to patients where tracheotomy was performed without dual antiplatelet therapy (n=52, 66%). Nonsignificant differences between the two groups were observed general characteristics. There were no statistically significant differences in complications after tracheotomy (surgical revision after tracheotomy p=0.63, bronchoscopy after tracheotomy p=0.74, blood transfusion after tracheotomy p=0.59, death attributed to tracheotomy p=1.00 and any complication attributed to tracheotomy p=1.00). The study shows that tracheotomy is safe in cardiac patients on dual antiplatelet therapy.

Opis fizyczny
  • Medical Intensive Care
    Unit, University Medical Centre Maribor, Ljubljanska 5, 2000 Maribor,
  • Medical Intensive Care
    Unit, University Medical Centre Maribor, Ljubljanska 5, 2000 Maribor,
  • Ear, Nose and Throat Diseases Department,
    University Medical Centre Maribor, Ljubljanska 5, 2000 Maribor,
  • [1] Hsu C.L., Chen K.Y., Chang C.H., Jerng J.S., Yu C.J., Yang P.C.,Timing of tracheostomy as a determinant of weaning successin critically ill patients: a retrospective study, Crit. Care., 2005;9: R46-5
  • [2] Heffner J.E., Miller K.S., Sahn S.A., Tracheostomy inthe intensive care unit. Part 1: Indications, technique,management, Chest, 1986; 90: 269-274
  • [3] Combes A., Luyt C.E., Nieszkowska A., Trouillet J.L., Gibert C.,Chastre J., Is tracheostomy associated with better outcomes forpatients requiring long-term mechanical ventilation?, Crit. Care.Med., 2007; 35: 802-807[WoS]
  • [4] Heffner J.E., Medical indications for tracheotomy, Chest, 1989;96: 186-190
  • [5] Upadhyay A., Maurer J., Turner J., Tiszenkel H., Rosengart T.,Elective bedside tracheostomy in the intensive care unit, J. Am.Coll. Surg., 1996; 183: 51-55
  • [6] Korte W., Cattaneo M., Chassot P.G., Eichinger S., vonHeymann C., Hofmann N. et al., Peri-operative management ofantiplatelet therapy in patients with coronary artery disease:joint position paper by members of the working group onPerioperative Haemostasis of the Society on Thrombosisand Haemostasis Research (GTH), the working group onPerioperative Coagulation of the Austrian Society for Anesthesiology,Resuscitation and Intensive Care (ÖGARI) and theWorking Group Thrombosis of the European Society forCardiology (ESC), Thromb. Haemost., 2011; 105: 743-749, doi:10.1160/TH10-04-0217[Crossref]
  • [7] Fitchett D., Eikelboom J., Fremes S., Mazer D., Singh S., BittiraB. et al., Dual antiplatelet therapy in patients requiring urgentcoronary artery bypass grafting surgery: a position statementof the Canadian Cardiovascular Society, Can. J. Cardiol., 2009;25: 683-689[WoS]
  • [8] Voigt I., Naber C., Bleeding complications of percutaneousdilatation tracheostomy (PDT) in a group of ICU patients withdual antiplatelet therapy, Crit. Care. Shock, 2012; 15: 70-76
  • [9] Sharma S.C., Singh V.K., Anand A., Rao B.K., Percutaneoustracheostomy in patients with coagulopathy, In: J.D. Chiche(Ed.), Abstract of the 23rd ESICM Annual Congress, 2010: 163
  • [10] Beiderlinden M., Eikermann M., Lehmann N., Adamzik M.,Peters J., Risk factors associated with bleeding during and afterpercutaneous dilational tracheostomy, Anaesthesia, 2007; 62:342-346[WoS]
  • [11] Kluge S., Meyer A., Kühnelt P., Baumann H.J., Kreymann G.,Percutaneous tracheostomy is safe in patients with severethrombocytopenia, Chest, 2004; 126: 547-551
  • [12] Auzinger G., O’Callaghan G.P., Bernal W., Sizer E., WendonJ.A., Percutaneous Tracheostomy in patients with severe liverdisease and a high incidence of refractory coagulopathy: aprospective trial, Crit. Care., 2007; 11: R110[WoS][Crossref]
  • [13] Blankenship D.R., Kulbersh B.D., Gourin C.G., Blanchard A.R.,Terris D.J., High-risk tracheostomy: exploring the limits of thepercutaneous tracheostomy, Laryngoscope, 2005; 115: 987-989
  • [14] Blot F., Nitenberg G., Guiguet M., Casetta M., Antoun S., PicoJ.L. et al., Safety of tracheotomy in neutropenic patients: aretrospective study of 26 consecutive cases, Intensive CareMed, 1995; 21: 687-690
  • [15] Rayess H.M., Revenaugh P.C., Benninger M.S., Knott P.D.,Predictive factors for patient outcomes following open bedsidetracheotomy, Laryngoscope, 2013; 123: 923-928, doi: 10.1002/lary.23887[WoS][Crossref]
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.